LEVEL is strengthening real-world tested cannabinoids with an independent 29-day study of its Relief Protab involving 427 adults experiencing ongoing aches and pain. Following a seven-day baseline, participants used the hemp tablet for 21 days while reporting pain and quality-of-life measures. Same-day pain scores fell 32% within hours of dosing, while 80% of participants reported reduced daily pain. The observational study had no placebo control, meaning its findings reflect participant-reported experiences rather than establishing clinical efficacy.
For LEVEL, testing the finished formulation rather than relying only on research surrounding individual ingredients creates greater transparency around how consumers experience the actual product. This evidence-focused strategy can help differentiate the company within a crowded cannabinoid market where finished-product research remains limited. Conducting similar studies across its portfolio could also give LEVEL a consistent framework for product development, consumer education, and evidence-based marketing while building greater confidence in its formulations.
Image Credit: LEVEL
What's Driving This Trend
- Finished-product Evidence
- Brands that test complete cannabinoid formulations rather than isolated ingredients create clearer differentiation in wellness markets where consumer trust depends on product-specific proof.
- Real-world Wellness Data
- Participant-reported outcomes from everyday product use are becoming valuable signals for understanding perceived benefits, quality-of-life changes, and market relevance outside clinical settings.
- Transparent Cannabinoid Validation
- Evidence-focused positioning gives hemp and cannabinoid companies a pathway to stand out as consumers seek clearer substantiation for relief-oriented products.
Who This Affects Most
- Cannabinoid Wellness
- Crowded cannabinoid categories are opening space for companies that pair formulation innovation with accessible research narratives that support consumer confidence.
- Pain Relief Products
- Non-prescription relief markets are being reshaped by alternative formats that combine convenience, measured dosing, and experience-based validation.
- Consumer Health Research
- Observational studies and digital self-reporting tools are expanding how wellness brands generate practical evidence around finished products and user outcomes.
